ArticleCancers2020

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis.

Aya Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.